Filing Details
- Accession Number:
- 0000950170-24-022242
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-28 17:06:00
- Reporting Period:
- 2024-02-28
- Accepted Time:
- 2024-02-28 17:06:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818794 | Dyne Therapeutics Inc. | DYN | Pharmaceutical Preparations (2834) | 364883909 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1847941 | Wildon Farwell | 1560 Trapelo Road Waltham MA 02451 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-02-28 | 407 | $25.00 | 163,096 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 14, 2023.
- Includes 140,510 unvested RSUs.
Billionaire Hedge Funds
